We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $299M Turnover 13.67%
1-Year Est. Return 53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
Cap. Flow
+$8.26M
Cap. Flow %
2.77%
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held Equity + Options
3.4 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.4 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
2.3 years

Top Buys

Rank Stock Value
1
FHLC icon
Fidelity MSCI Health Care Index ETF
FHLC
+$18.3M
2
SIBN icon
SI-BONE Inc
SIBN
+$3.79M
3
DUOT icon
Duos Technologies
DUOT
+$2.91M
4
APGE icon
Apogee Therapeutics
APGE
+$2.91M
5
NPCE icon
Neuropace
NPCE
+$1.61M

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$9.41M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.14M
3
ANAB icon
AnaptysBio
ANAB
+$3.29M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.64M
5
PIPR icon
Piper Sandler
PIPR
+$1.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.9%
2 Healthcare 21.84%
3 Technology 4.77%
4 Financials 3.58%
5 Industrials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IVV icon
1
iShares Core S&P 500 ETF
IVV
$884B
$82.3M 27.57%
109,892
-7,063
-6% -$5.14M
2019 Q4
26 quarters
FHLC icon
2
Fidelity MSCI Health Care Index ETF
FHLC
$3.74B
$19.7M 6.58%
254,403
+254,395
+3,179,938% +$18.3M
2022 Q2
16 quarters
AXGN icon
3
Axogen
AXGN
$2.07B
$15.8M 5.28%
341,390
-3,550
-1% -$143K
2020 Q3
23 quarters
IWM icon
4
iShares Russell 2000 ETF
IWM
$77.8B
$15.3M 5.13%
51,019
-3,597
-7% -$1.01M
2021 Q4
18 quarters
EFV icon
5
iShares MSCI EAFE Value ETF
EFV
$30.3B
$15.2M 5.11%
199,183
-21,158
-10% -$1.64M
2019 Q4
26 quarters
IJR icon
6
iShares Core S&P Small-Cap ETF
IJR
$102B
$13.3M 4.47%
89,888
-797
-0.9% -$109K
2019 Q4
26 quarters
VOO icon
7
Vanguard S&P 500 ETF
VOO
$1.04T
$10.7M 3.57%
15,529
-982
-6% -$655K
2019 Q4
26 quarters
NEO icon
8
NeoGenomics
NEO
$2.11B
$8.94M 2.99%
612,534
+32,700
+6% +$316K
2020 Q2
24 quarters
IUSV icon
9
iShares Core S&P US Value ETF
IUSV
$27.9B
$8.32M 2.79%
75,506
-5,033
-6% -$545K
2019 Q4
26 quarters
SIBN icon
10
SI-BONE Inc
SIBN
$881M
$6.94M 2.32%
425,049
+265,217
+166% +$3.79M
2023 Q4
10 quarters
DWAS icon
11
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$379M
$5.92M 1.98%
46,538
-319
-0.7% -$36.2K
2023 Q4
10 quarters
WFC icon
12
Wells Fargo
WFC
$246B
$5.67M 1.9%
68,644
+47
+0.1% +$3.78K
2019 Q4
26 quarters
IJH icon
13
iShares Core S&P Mid-Cap ETF
IJH
$121B
$4.81M 1.61%
62,399
+1,700
+3% +$125K
2019 Q4
26 quarters
APGE icon
14
DELISTED
Apogee Therapeutics
APGE
$4.28M 1.43%
+32,266
New +$2.91M
2026 Q2
0 quarters
TWST icon
15
Twist Bioscience
TWST
$9.27B
$4.02M 1.35%
39,030
-260
-0.7% -$16.9K
2024 Q4
6 quarters
DUOT icon
16
Duos Technologies
DUOT
$172M
$3.48M 1.17%
+289,884
New +$2.91M
2026 Q2
0 quarters
TLT icon
17
iShares 20+ Year Treasury Bond ETF
TLT
$47.7B
$3.12M 1.05%
36,113
+372
+1% +$31.9K
2025 Q2
4 quarters
MASS icon
18
908 Devices
MASS
$472M
$2.96M 0.99%
339,783
+20,433
+6% +$157K
2025 Q4
2 quarters
ANAB icon
19
AnaptysBio
ANAB
$1.47B
$2.68M 0.9%
39,716
-54,334
-58% -$3.29M
2025 Q1
5 quarters
NPCE icon
20
Neuropace
NPCE
$438M
$2.59M 0.87%
163,000
+100,000
+159% +$1.61M
2024 Q3
7 quarters
NVDA icon
21
NVIDIA
NVDA
$5.24T
$2.37M 0.79%
11,844
-931
-7% -$191K
2019 Q4
26 quarters
ATRC icon
22
AtriCure
ATRC
$2.82B
$2.34M 0.78%
83,720
– –
2022 Q1
17 quarters
AAPL icon
23
Apple
AAPL
$5T
$2.2M 0.74%
7,608
-232
-3% -$66.4K
2019 Q4
26 quarters
EWTX icon
24
Edgewise Therapeutics
EWTX
$4.12B
$2.16M 0.72%
53,179
– –
2024 Q4
6 quarters
LLY icon
25
Eli Lilly
LLY
$1.11T
$2.08M 0.7%
1,734
+6
+0.3% +$6.13K
2019 Q4
26 quarters
1
2 3 4 5

Similar funds

GWM
Glass Wealth Management San Antonio, Texas $299M AUM 66.9% 1-Year Est. Return
HP
Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return
SC
Sawyer & Company Boston, Massachusetts $298M AUM 31.71% 1-Year Est. Return
ACC
Acorn Creek Capital Fort Collins, Colorado $299M AUM 23.67% 1-Year Est. Return
AIM
Avanda Investment Management Singapore $299M AUM 50.34% 1-Year Est. Return
SEM
Strategic Equity Management Tucson, Arizona $298M AUM 27.02% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $299M AUM 41.44% 1-Year Est. Return
SIIL
Sinvest Investments II Ltd Nassau, New Providence $298M AUM

HighMark Wealth Management's Q2 2026 Portfolio in Review

As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.

  • HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
  • HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
  • HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
  • HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
  • HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
  • HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.